Sachiko Kitamura

No ORCID on file · 7 papers in corpus · active 2017-2026

Study types

  • article 3
  • other 2
  • preprint 1
  • review 1

Condition tags

  • endometriosis 7
other 2026
International journal of cancer ·doi:10.1002/ijc.70341

Ovarian clear cell carcinoma (CCC) is an aggressive subtype of ovarian cancer that is resistant to conventional chemotherapy, resulting in poor prognosis. CCC develops from endometriosis, which exposes tumor cells to a hypoxic microenvironm…

article 2024
Turkish journal of obstetrics and gynecology ·doi:10.4274/tjod.galenos.2024.59019

OBJECTIVE: Endometriosis is associated with various symptoms, but their severity varies from case to case. In this study, we investigated the reality of symptoms presented by patients with clinically early-stage endometriosis-associated ova…

article 2023
·doi:10.1158/1538-7445.am2023-128

Abstract Introduction: The epithelial cells of the endometrium undergo rapid proliferation and shedding each month under the influence of estrogen and progesterone. Recent studies have demonstrated pervasive driver mutations in the endometr…

preprint 2023
·doi:10.21203/rs.3.rs-2762748/v1
review 2021
Cancers ·doi:10.3390/cancers13102413

Clear cell carcinoma (CCC) of the ovary exhibits a unique morphology and clinically malignant behavior. The eosinophilic cytoplasm includes abundant glycogen. Although the growth is slow, the prognosis is poor owing to resistance to convent…

other 2021
Cancer science ·doi:10.1111/cas.15125

Ovarian clear cell carcinoma (CCC) exhibits an association with endometriosis, resistance to oxidative stress, and poor prognosis owing to its resistance to conventional platinum-based chemotherapy. A greater understanding of the molecular …

article 2017
BJR case reports ·doi:10.1259/bjrcr.20170062

Endometrioid borderline tumours (EBTs) of the ovary are uncommon tumours of low malignant potential. They consist of atypical endometrioid cells lacking destructive stromal invasion. As the prognosis of EBT is excellent, excessive treatment…